Press Releases & Articles
Novaseek is pursuing CROs and pharmas to employ its clinical data platform, Clinical Data Network for Research (CDNR), said CEO Kate Torchilin in an interview with this news service at the Biotech Showcase conference in San Francisco.
PharmaVoice 2017: “All of us in life sciences and healthcare are privileged to be working in an industry that is constantly evolving and re-inventing itself to better serve patients and help them live healthier lives. Of course, the patient is always the central theme of everything that we do; however, as we move into 2017, […]
With its goal of streamlining the process of collecting patient data, Cambridge, Massachusetts-based start-up Novaseek is tackling one of the more challenging portions of the diagnostics and drug-development processes.
— Biospecimens enriched with deep data insights for population analytics, prospective patient tracking and more — CAMBRIDGE, MA, Jan. 9, 2017– Novaseek Research LLC today announced that its Clinical Data Network for Research (CDNR) platform was recently enhanced to include the capability to dynamically collect biospecimens and clinical data from patients during the course of […]
More Press Releases & Articles
Technological advances in an ever-changing healthcare environment, including the digitization of patient health records, have had a significant impact on the development of new therapies. Since first being used to support a drug’s value, real-world data (RWD) is now being pulled into the R&D process at earlier stages to impact the development of new medicines […]
Last Thursday Novaseek Research had the chance to listen in on the Harvard Business School Kraft Precision Medicine Accelerator Oncology Data Landscape Update call. The Kraft Accelerator was established last year to speed breakthroughs in precision medicine. The Accelerator aims to enable faster commercialization of high-impact innovations by addressing challenges that slow the advancement of […]
Last month I had the opportunity to present Novaseek’s CDNR platform at the second annual Digital Medicine Showcase. This event is a part of the Biotech Showcase event that takes place during the J.P. Morgan Annual Healthcare Conference. Digital Medicine Showcase brings together innovative companies and gives them a forum to present their clinically impactful […]
Last month, Foundation Medicine and Flatiron Health announced an initiative to assemble large genomic databases built around the electronic health records (EHRs), of 20,000 cancer patients. The purpose of this initiative would be to provide a real world data-based tool for oncology reseachers. It’s exciting to think about the possibilities that this type of database […]
With the advance of precision medicine, ensuring that clinical studies more accurately reflect real-world patients needs to be at the heart of drug discovery and development. Historically, one of the reasons that so many studies fail is because patient cohorts are often not defined optimally for the treatment being investigated. Step one in changing this […]
More Blog Posts
Precision medicine is an exciting area of innovation for researchers in academia and industry. It holds the promise of better outcomes for patients, and it is changing the way patients experience disease and treatment. By definition, the patient population for a targeted medicine is smaller than that of the disease category as a whole. Medicines affect patients differently.1 […]